|
|
Volumn 111, Issue 3, 2001, Pages 185-191
|
|
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
ATORVASTATIN;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
STATIN;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BODY MASS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROENTERITIS;
HUMAN;
HYPERCHOLESTEROLEMIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MUSCLE CRAMP;
MYALGIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RISK FACTOR;
AGED;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
DRUG ADMINISTRATION SCHEDULE;
FATTY ACIDS, MONOUNSATURATED;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INDOLES;
LOVASTATIN;
MALE;
MIDDLE AGED;
PATIENT EDUCATION;
PRAVASTATIN;
PYRROLES;
RISK;
RISK FACTORS;
SIMVASTATIN;
TREATMENT OUTCOME;
TRIGLYCERIDES;
UNITED STATES;
|
|
EID: 0035881018
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(01)00799-9 Document Type: Article |
|
Times cited : (163)
|
|
References (13)
|
